Virginia Retirement Systems Et Al Organogenesis Holdings Inc. Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 17, 2023
SELL
$2.48 - $3.43 $3,968 - $5,488
-1,600 Reduced 4.48%
34,100 $91.7 Million
Q3 2022

May 16, 2023
SELL
$3.14 - $6.43 $43,646 - $89,377
-13,900 Reduced 28.02%
35,700 $116 Million
Q1 2022

Apr 21, 2022
BUY
$6.47 - $9.57 $96,403 - $142,593
14,900 Added 42.94%
49,600 $378,000
Q4 2021

Feb 03, 2022
BUY
$9.02 - $13.5 $312,994 - $468,450
34,700 New
34,700 $321,000

Others Institutions Holding ORGO

# of Institutions
120
Shares Held
63.9M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $453M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email